Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.
Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials.
Assessment of the effect of interferon-beta1a therapy on thyroid and salivary gland functions in patients with multiple sclerosis using quantitative salivary gland scintigraphyz.
Narcolepsy with cataplexy and comorbid immunopathological diseases.
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells.
Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis.
Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less Frequent Dosing of Three-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg Compared to Daily COPAXONE® 20 mg
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.
Interference with RhoA-ROCK Signaling Mechanism in Autoreactive CD4(+) T Cells Enhances the Bioavailability of 1,25-Dihydroxyvitamin D(3) in Experimental Autoimmune Encephalomyelitis.
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis.
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.
Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.
A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica).
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
Pharmacokinetics of fingolimod (FTY720) and a combined oral contraceptive coadministered in healthy women: drug-drug interaction study results.
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis.
Administration of monthly-pulse cyclophosphamide in multiple sclerosis patients. Effects of long-term treatment on immunologic parameters.
Clinical overview of the seizure risk of dalfampridine.
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.

Pages